Cargando…
Higher thresholds for the utilization of steatotic allografts in liver transplantation: Analysis from a U.S. national database
BACKGROUND: Historically, liver allografts with >30% macrosteatosis (MaS) on donor biopsy have been associated with early allograft dysfunction and worse graft survival; however, successful outcomes have been reported in small cohorts. This study proposes an elevated MaS threshold for organ utili...
Autores principales: | Steggerda, Justin A., Bloom, Matthew B., Noureddin, Mazen, Brennan, Todd V., Todo, Tsuyoshi, Nissen, Nicholas N., Klein, Andrew S., Kim, Irene K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7117730/ https://www.ncbi.nlm.nih.gov/pubmed/32240235 http://dx.doi.org/10.1371/journal.pone.0230995 |
Ejemplares similares
-
Clinical considerations in the management of non-alcoholic steatohepatitis cirrhosis pre- and post-transplant: A multi-system challenge
por: Steggerda, Justin A, et al.
Publicado: (2020) -
A Clinical Tool to Guide Selection and Utilization of Marginal Donor Livers With Graft Steatosis in Liver Transplantation
por: Steggerda, Justin A., et al.
Publicado: (2022) -
Acute Kidney Injury Patterns Following Transplantation of Steatotic Liver Allografts
por: Jadlowiec, Caroline, et al.
Publicado: (2020) -
Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis: The Patient and Physician Perspective
por: Eskridge, Wayne, et al.
Publicado: (2023) -
The impact of cortisol in steatotic and non‐steatotic liver surgery
por: Cornide‐Petronio, María Eugenia, et al.
Publicado: (2017)